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Abstract
Objective To determine the accuracy of iodine quantifi-
cation with dual energy computed tomography (DECT)
in two high-end CT systems with different spectral im-
aging techniques.
Methods Five tubes with different iodine concentrations (0, 5,
10, 15, 20 mg/ml) were analysed in an anthropomorphic tho-
racic phantom. Adding two phantom rings simulated in-
creased patient size. For third-generation dual source CT
(DSCT), tube voltage combinations of 150Sn and 70, 80,
90, 100 kVp were analysed. For dual layer CT (DLCT), 120
and 140 kVp were used. Scans were repeated three times.
Median normalized values and interquartile ranges (IQRs)
were calculated for all kVp settings and phantom sizes.
Results Correlation between measured and known iodine con-
centrations was excellent for both systems (R = 0.999–1.000,
p < 0.0001). For DSCT, median measurement errors ranged
from −0.5% (IQR −2.0, 2.0%) at 150Sn/70 kVp and −2.3%
(IQR −4.0, −0.1%) at 150Sn/80 kVp to −4.0% (IQR −6.0,
−2.8%) at 150Sn/90 kVp. For DLCT, median measurement
errors ranged from −3.3% (IQR −4.9, −1.5%) at 140 kVp to
−4.6% (IQR −6.0, −3.6%) at 120 kVp. Larger phantom sizes
increased variability of iodine measurements (p < 0.05).
Conclusion Iodine concentration can be accurately quantified
with state-of-the-art DECT systems from two vendors. The
lowest absolute errors were found for DSCT using the
150Sn/70 kVp or 150Sn/80 kVp combinations, which was
slightly more accurate than 140 kVp in DLCT.
Key Points
• High-end CT scanners allow accurate iodine quantification
using different DECT techniques.
• Lowest measurement error was found in scans with largest
photon energy separation.
• Dual-source CT quantified iodine slightly more accurately
than dual layer CT.
Keywords Tomography, x-ray computed . Absorptiometry,
photon .Myocardial perfusion imaging . Iodine . Phantoms,
imaging
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MRI Magnetic resonance imaging
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Coronary artery disease (CAD) remains a widespread disease
in the Western society. Moreover, the impact of CAD will in-
crease in the next decades because of the epidemic of obesity.
Cardiovascular disease (CVD) is the primary cause of death in
the USA and overall annual economic burden is substantial [1].
In 2010, medical costs with a direct relation to cardiovascular
disease were US$273 billion for the USA only [2].
Computed tomography (CT) angiography is a proven tech-
nique for the detection of coronary stenosis with high sensitiv-
ity and negative predictive value [3]. However, especially in
cases with intermediate stenosis it is often difficult to determine
whether a stenosis is significant or not. Myocardial perfusion
scanning under stress can help in the diagnostic process of
determining the significance of any indeterminate stenosis,
e.g. by single-photon emission computed tomography
(SPECT), positron emission tomography (PET) or magnetic
resonance imaging (MRI) [4]. Recent developments have
renewed interest for perfusion analysis using CT. One of the
methods to evaluate myocardial ischemia with CT is dual en-
ergy CT (DECT). In DECT, high energy x-ray photons are
differentiated from low energy x-ray photons. Because attenu-
ation of materials and tissues differs at different photon energies
[5–7], DECT allows for quantification of materials and tissues.
By quantifying iodinated contrast media the DECT technique
does not provide direct information about the blood flow but
provides an estimate of contrast distribution across the myocar-
dium at one point in time. However, iodine distribution has a
direct relation to the myocardial blood flow, and thus provides a
semi-quantitative biomarker for myocardial perfusion
Currently several DECT methods are available of which
two are analysed in this study: the dual source CT (DSCT)
whereby two x-ray tubes are operated at separate tube voltages
and the dual layer spectral CT (DLCT) where low energy
photons are absorbed in the first detector layer and high ener-
gy photons in the second detector layer [5, 8, 9]. Koonce et al.
found good stability and accuracy of the iodine content deter-
mination on DSCT scanners, using options available at that
time [10]. Since then, third-generation DSCT has become
available, providing the possibility to use a tin filter with a
high tube voltage of 150 kVp, resulting in a narrow spectrum
of photons at a higher energy and larger spectral separation
with the low tube voltages (down to 70 kVp). Furthermore,
the first generation of DLCT has been recently introduced in
the clinic. It is expected that a high tube voltage (140 kVp)
results in better spectral separation compared to a lower tube
voltage (120 kVp) and thus in more accurate iodine quantifi-
cation; however, the performance in iodine quantification
using DLCT is still unknown. Therefore the aim of the current
study was to determine the accuracy of the quantification of
iodine concentrations on third-generation DSCT and first-
generation DLCT in a phantom.
Materials and methods
Phantom description
An anthropomorphic phantom (Cardio CT phantom,
QRM, Möhrendorf, Germany) was used to simulate the
human thorax. This thorax phantom contained artificial
lungs, spine, body fat and a cavity at the position of the
heart. The cavity was filled with a Perspex holder carry-
ing five separate tubes. These 15-ml tubes were filled
with diluted contrast solutions (Hexabrix 320 mg iodine/
ml, Guerbet, Paris, France), resulting in concentrations of
0, 5, 10, 15 and 20 mg of iodine per ml, one tube for each
concentration. The Perspex holder was placed in a water
container in the centre of the cardiac cavity, surrounding
the iodine tubes and the Perspex holder with water.
Different patient sizes were simulated using extension
rings with densities comparable to fat (Extension rings,
QRM, Möhrendorf, Germany), which were placed around
the thorax. Two separate fat rings were used, providing
image data of simulated small, medium and large patient
sizes (Fig. 1).
Image acquisition
Image acquisition was performed in dual energy mode on
third-generation DSCT (SOMATOM Force, Siemens
Healthcare, Forchheim, Germany) and first-generation
DLCT (IQon spectral CT, Philips Healthcare, Best, the
Netherlands). For DSCT, 150 kVp with tin (Sn) filter
was used as the high tube voltage in combination with
low tube voltages of 70, 80, 90 and 100 kVp in spiral
scan mode. For DLCT, tube voltages of 140 and 120
kVp were used in spiral scan mode. Tube currents for
DSCT were 165 mAs/rot at low tube voltage and 150
mAs/rot at the high tube voltage (vendor-recommended
protocol). Tube current of 200 mAs was used for DLCT,
as part of a clinical use protocol. This mAs was selected
in order to acquire DECT data at comparable radiation
doses for DSCT and DLCT. For DSCT, mean CT dose
index (CTDIvol) gradually increased when raising the
low tube voltages of the DSCT combinations, from
18.7 mGy for 150Sn/70 kVp and 22.1 mGy for 150Sn/
80 kVp to 26.9 mGy for 150Sn/90 kVp and 32.2 mGy for
150Sn/100 kVp. For DLCT, mean CTDIvol for the 140
kVp tube voltage was 26.0 mGy, while 120-kVp tube
voltage resulted in a CTDIvol of 18.1 mGy. All acquisi-
tions were repeated three times with small translations and
rotations between the separate scan repetitions. Various
grades of iterative reconstruction (IR) were used to ana-
lyse the influence of increased IR on iodine quantifica-
tion. Third-generation DSCT data were reconstructed with
a previously described IR algorithm (ADMIRE, Siemens
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Healthcare, Forchheim, Germany) [11, 12], whereas
DLCT data were reconstructed with a model-based itera-
tive reconstruction algorithm taking into account anti-
correlated noise. DSCT data were reconstructed using
four settings: IR grades 0, 1, 3 and 5. DLCT data were
reconstructed using spectral levels of 0, 2, 4 and 6. For
DSCT, scans were acquired with a gantry rotation time of
250 ms, a pitch of 0.19 and a detector collimation of 2 ×
64 × 0.6 mm. DLCT scans were acquired with a gantry
rotation time of 330 ms, a pitch of 0.18 and a detector
collimation of 64 × 0.625 mm.
Image analysis and iodine quantification
Images were reconstructed at 3.0 mm slice thickness with an
increment of 1.5 mm using the standard kernel settings. The
images of the separate systems were analysed using vendor-
specific software, Syngo.via software VB10 (Siemens,
Forchheim, Germany) for DSCT and Spectral Diagnostic
Suite (Philips Healthcare, Best, the Netherlands) for DLCT.
In Syngo.via a dedicated DECT pack ‘Special’ was used and
analysis was performed in ‘virtual unenhanced’ setting. In the
Spectral Diagnostic Suite, image analysis is performed native-
ly in spectral CT mode. For each iodine tube at each scan, one
region of interest (ROI) was drawn in the coronal plane to
maximize ROI areas; each ROI was at least 5.0 cm2. Themean
iodine concentration in the ROI was calculated by the dedi-
cated software packages of each vendor. DECT iodine con-
centration measurements were compared to the known iodine
contrast concentration. Normalized difference of concentra-
tion measurements was calculated by dividing the difference
between the CT-measured and the known concentration by the
known concentration for all separate measurements.
Statistical analysis
Statistical analysis was performed using SPSS version 23
(IBM Corp, Armonk, NY, USA). Pearson correlation be-
tween the CT-measured and known iodine concentration
was determined for all DECT scans. Median absolute mea-
surement errors, as well as normalized measurement errors,
were calculated for each possibly influencing factor, e.g.
number of fat rings, IR grade and tube voltage combina-
tion. Kendall’s Tau b (τb) as a measure of trends and cor-
relation was determined between IR grades and iodine
measures on both CT systems, and between patient size
and iodine measures on the two CT systems. Median nor-
malized iodine measurement errors were used to identify
the CT protocols with the smallest iodine measurement
error and interquartile ranges (IQR) compared to known
concentrations. Furthermore, normalized differences in io-
dine quantification were compared for scan protocols with
lowest measurement error at both CT systems using the
Mann–Whitney U test. Normalized differences in iodine
quantification were compared for different patient sizes
using the Kruskal–Wallis test. Variances were compared
for several kVp combinations and patient sizes in order to
acquire information about the stability and consistency of
the separate DECT protocols. Variances in normalized io-
dine measurement differences were compared for the scan
protocols with lowest measurement error using Levene’s
test for equality of variances.
Fig. 1 QRM iodine
quantification setup, including the





In total, 720 measurements were performed on DSCT scan
data (3 repetitions × 5 concentration grades × 3 patient sizes ×
4 iterative reconstruction grades × 4 kVp combinations).
Correlation between measured and true iodine concentration
was excellent at all kVp combinations (R = 0.999–1.000,
p < 0.0001). For the 150Sn/70 kVp combination, the measure-
ment error was smallest with a median difference of −0.5%
(IQR −2.0, 2.0%) and a median absolute error of −0.1 mg/ml
(IQR −0.2, 0.2 mg/ml). The median difference was slightly
larger for 150Sn/80 kVp and 150Sn/100 kVp, −2.3% (IQR
−4.0%, −0.1%) and −2.3% (IQR −5.0, −1.1) with an absolute
error of −0.2 mg/ml (IQR −0.3, −0.1 mg/ml) and −0.2 mg/ml
(IQR −0.5, −0.1 mg/ml). The other kVp combinations showed
more underestimation (Fig. 2, Table 1).
No significant correlation was found between normalized
iodine measurement error and different grades of IR, which
implies that the addition of IR does not influence iodine con-
centration measurements for third-generation DSCT (Kendall
τb test, 150Sn/70 p = 0.81, 150Sn/80 p = 0.85, 150Sn/90 p =
0.66, 150Sn/100 p = 0.59). For all kVp combinations, an in-
crease in patient size resulted in slightly higher median iodine
measurements; however, there were no significant trends
(Kendall τb test, 150Sn/70 τb > 0.07, p = 0.53; 150Sn/80
τb > 0.06, p = 0.62; 150Sn/90 τb > 0.05, p = 0.69; 150Sn/100
τb > 0.03, p = 0.79) (Fig. 3). For the 150Sn/70, 150Sn/80 and
150Sn/90 kVp combinations, normalized measurement error
between CT-determined and known iodine concentration was
significantly different between three patient sizes (Kruskal–
Wallis test, p < 0.05). Only the 150Sn/100 kVp combination
showed no significant difference when comparing the normal-
ized measurement error between the three patient sizes
(Kruskal–Wallis test, p = 0.16). The Levene’s variance test
showed no significant difference in variance for normalized
measurement error between 150Sn/70 and 150Sn/80 kVp
combination in any patient size (small: p = 0.06; medium
p = 0.52; large p = 0.46). The 150Sn/100 kVp combination
showed significantly larger variances in medium patient size
compared to the 150Sn/70 kVp protocol (Levene’s test,
p < 0.05). Furthermore, the variance of the normalized mea-
surement error of the 150Sn/100 kVp combination was sig-
nificantly larger in small and medium patient sizes compared
to the corresponding patient size groups for the 150Sn/80 kVp
protocol (Levene’s test, p < 0.05).
First-generation DLCT
In total, 360 measurements were performed on DLCT scan
data (3 repetitions × 5 concentration grades × 3 patient sizes ×
4 iterative reconstruction grades × 2 kVp tube voltages).
Correlations between measured and known iodine concentra-
tions were excellent for both kVp combinations (R = 0.999–
1.000, p < 0.0001). Median measurement error for 140 kVp
was −4.0% (IQR −6.0, −1.6%) with an absolute median devi-
ation of −0.3 mg/ml (IQR −0.6, −0.1 mg/ml) (Fig. 4, Table 1).
The 120 kVp setting showed more underestimation of the
iodine content in the tubes (median measurement error,
−5.0% (IQR −7.0, −4.0%) median absolute difference,
−0.6 mg/ml (IQR −0.8, −0.3 mg/ml) (p < 0.05)).
Different grades of model-based iterative reconstruction
settings did not influence iodine quantification (Kendall τb
test, 120 kVp p = 0.80, 140 kVp p = 0.59). For both kVp com-
binations, an increase in patient size resulted in lower mea-
sured iodine concentrations, although not significant using
Kendall’s τb test (120 kVp τb < −0.11, p = 0.36; 140 kVp τb
< −0.13 p = 0.30) (Fig. 5). Large patient size showed more
underestimation of iodine concentrations compared to medi-
um and small patient size for both the tube voltages (Kruskal–
Wallis test, p < 0.05). No significant difference in variance
was found between the two tube voltages in any patient size
(Levene’s test, small p = 0.25, medium p = 0.92, large p =
0.50).
Comparison between third-generation DSCT
and first-generation DLCT
A significant difference was found for the normalized differ-
ence between CT-measured and known iodine concentration
between the DSCT 150Sn/70 and the DLCT 140 kVp tube
voltage (Mann–Whitney U test, p < 0.05), indicating closer
agreement with known iodine concentrations for the DSCT
150Sn/70 kVp combination. Similarly, measurement error
was smaller for 150Sn/80 kVp DSCT compared to 140 kVp
DLCT (Mann–Whitney U test, p < 0.05). However, no signif-
icant difference in normalized measurement error was found
when 150Sn/100 kVp DSCT was compared to 140 kVp
DLCT (Mann–Whitney U test, p = 0.21). No significant dif-
ference in variances was found for all of the DSCT kVp com-
binations when compared to DLCT 140 kVp (Levene’s vari-
ance test, 150Sn70 vs. 140 kVp: p = 0.91; 150Sn80 vs. 140
kVp: p = 0.08). Also when analysing patient sizes separately,
no significant differences in variance were found (Levene’s
variance test, 150Sn70 vs. 140 kVp: small p = 0.52, medium
p = 0.44, large = 0.77; 150Sn80 vs. 140 kVp: small p = 0.18,
medium p = 0.82, large = 0.24).
Discussion
In this study the accuracy of iodine quantification using
DECT was studied in third-generation DSCT system and
first-generation DLCT. Using a phantom model, we showed
that the correlation of iodine measurements with true
Eur Radiol
concentrations was excellent for both DSCT and DLCT. The
results suggest that iodine quantification in the myocardium
could be a semi-quantitative surrogate for the quantification of
myocardial perfusion, with iodine concentration in the myo-
cardium as an expression of the blood distribution at one mo-
ment in time. The most accurate results were found for proto-
cols with the largest photon energy separation, namely 150Sn/
70 and 150Sn/80 kVp for DSCT and 140 kVp for DLCT.
Koonce et al. analysed iodine quantification using DECT
for first- and second-generation DSCT systems [10]. That
study demonstrated stable and accurate results for multiple
acquisition protocols. Our results complement that study, with
even closer or comparable agreement between CT-measured
and known iodine concentration for two new state-of-the-art
CT systems, a third-generation DSCT system and a first-
generation DLCT system. Another study analysed iodine
quantification on single-source CT with a split filter, with
measured differences ranging between 2 and 21% for iodine
concentrations ranging from 1.2 to 23.5 mg/ml, with absolute
differences ranging from 0.1 to 1.6 mg/ml [13]. When
























































Fig. 2 Normalized difference
between CT-measured and known
iodine concentrations is shown
for each DSCT kVp combination
by true iodine concentration
Table 1 Median CT-measured iodine concentration and normalized differences between CT-measured and known iodine concentration are shown for
both DSCT and DLCT
Dual source CT Dual layer CT
Iodine concentration 150Sn/70 150Sn/80 150Sn/90 150Sn/100 120 kVp 140 kVp
0 mg/ml (%) −0.1 −0.1 −0.1 −0.1 0 0
5 mg/ml (%) 4.8 (−4%) 4.8 (−4%) 4.5 (−10%) 4.6 (−8%) 4.5 (−10%) 4.7 (−6%)
10 mg/ml (%) 10.0 (0%) 9.9 (−1%) 9.6 (−4%) 9.8 (−2%) 9.6 (−4%) 9.7 (−3%)
15 mg/ml (%) 15.1 (1%) 15.0 (0%) 14.6 (−3%) 14.8 (−1%) 14.3 (−5%) 14.5 (−3%)
20 mg/ml (%) 19.8 (−1%) 19.3 (−4%) 18.9 (−6%) 19.1 (−5%) 19.3 (−4%) 19.7 (−2%)
Median diff concentration grades mg/ml (%) −0.1 (−1%) −0.2 (−2%) −0.4 (−4%) −0.2 (−2%) −0.5 (−5%) −0.3 (−3%)
Median difference for the separate kVp combinations is shown
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comparing these results to our study, one can state that in-
creased spectral separation increases the accuracy of iodine
quantification.
Only one study analysed the quantification of iodine in
patients using a second-generation DSCT system [14]. The
authors concluded that quantification of iodine could be
useful for differentiation between normal, ischemic and ne-
crotic myocardium. Reference iodine values for normal and
ischemic myocardium were reported to be 2.6 and 2.0 mg/
ml, respectively. In our study, the low iodine concentrations
in the range of 0 to 5 mg/ml resulted in 0.2 to 0.3 mg/ml
underestimations using the optimal kVp combination of
150Sn/70, 150Sn/80 for DSCT and 140 kVp for DLCT.
Taking into account the small differences between normal
and ischemic myocardium as reported by Delgado et al. and
the results provided in this study, one should be careful to
crosslink iodine quantification results between scanners and
kVp combinations. Results of iodine quantification studies
can only be compared when the same scanner type and kVp
combination is used.
DECT cannot only be used in quantification of iodine con-
centration in the myocardium but also has the potential to
assess patency of coronary arteries, a standard CT angiogra-
phy [15, 16]. The use of only a slightly changed cardiac CT
protocol and the ability to compare stress images to rest
(coronary CTA) images are advantages of DECT compared
to dynamic first-pass perfusion CT. Furthermore, radiation
dose of a single-shot DECT scan is lower than the radiation
dose in dynamic perfusion CT. In comparison to DECT, a
major advantage of the dynamic first-pass perfusion CT is
the ability to quantify absolute myocardial perfusion, and de-
rive myocardial blood flow and blood volume. However,
DECTallows for assessment of a semi-quantitative biomarker
of myocardial perfusion, namely myocardial iodine content.
Quantification of myocardial iodine content may help in de-
tection ofmyocardial ischemia [14]. For this purpose, accurate
quantification of iodine content, as we have studied, is an
important issue. The quantification of iodine using DECTonly
calculates a semi-quantitative parameter of myocardial perfu-
sion, namely myocardial iodine distribution in milligrams per
millilitre. Still, this may bemore sensitive to detect myocardial
ischemia than mere visual evaluation. In this study, we
showed that the ability to quantify iodine is highly accurate.
Future studies should show whether quantification of myocar-
dial iodine distribution has additional diagnostic value in pa-
tients suspected of myocardial ischemia, beyond visual anal-
ysis of myocardial iodine distribution.
It is important to strive for a quantitative analysis of myo-
cardial blood supply. Quantitative analysis may allow more

























































Fig. 3 Normalized difference
between the CT-measured and
known iodine concentration is
shown for the kVp combinations
available at DSCT by patient size.
An increase in CT-determined io-
dine can be distinguished for all
kVp combinations, although the
trend was not significant
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of relative, visual analysis. This is of particular importance in
three-vessel disease, in which the entire myocardium may
have reduced perfusion. Three-vessel disease can be missed
when using qualitative assessment of relative contrast distri-
bution. Also, quantification of myocardial perfusion parame-
ters, or iodine content, may possibly enable detection of sub-
clinical CAD, in which blood supply is reduced but yet with-
out gross perfusion defects. The added value of DECT using
iodine quantification is not only shown for cardiac imaging
but several studies have shown added value in oncological
imaging, differentiating between renal masses and cysts or
assessing treatment response [17–19].
The third-generation DSCT is equipped with a tin filter to
harden the high energy (150 kVp) spectrum. This filter ab-
sorbs low energy photons before they reach the phantom,
causing increased spectral separation. In DSCT, tube voltage,
tin filter and tube current can be selected for both tubes sepa-
rately. Drawbacks of the DSCT technique are the angular off-
set of the two image datasets, and a smaller field of view for
one of the two tubes. Furthermore, the dual energy mode in
DSCT needs to be selected, while in DLCT images can always
be reconstructed in DECTmode. First-generation DLCTscan-
ning uses a different method to acquire spectral separation.
The first layer of detectors registers the low energy photons,
while the second layer mainly detects the high energy
photons, resulting in spectral separation between the first
and second layer of the detector. An increase in tube voltage
will result in a larger spectral separation, because more high
energy photons will reach the second detector layer. There is
no angular offset because the high and low energy datasets are
acquired using the same source, and conventional images are
created using the information from both high and low energy
datasets. Drawbacks of DLCT include the low number of kVp
selections (120 and 140 kVp), and the fact that no filter can be
selected, as separation takes place at the level of the detector
and not at the x-ray tube. This could result in a higher radiation
dose. The smaller detector coverage of 64 rows is another
drawback of the DLCT technique. Finally, as both the high
and low energy datasets are acquired using the same source,
spectral separation is lower compared to DSCTand this could
result in less accurate iodine quantification, as we have shown
in our study. Whether this translates into clinically relevant
differences in diagnostic accuracy is unknown.
DECT allows for quantification of iodine concentrations in
a static phantom at several patient sizes. However, an increase
in patient size will result in differences in quantified iodine for
both DSCT and DLCT scanners. Interestingly, increase in pa-
tient size tended to have a positive effect (increase in CT-
measured iodine) on the normalized differences between CT-
determined and known iodine concentration in DSCT, while























































Fig. 4 Normalized differences
between the CT-measured and
known concentration are shown
for the DLCT tube voltages by
patient size
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having a negative effect (decrease in CT-measured iodine) on
the quantification of iodine in DLCT. Only the 150Sn/100
tube voltage combination showed no significant difference
in normalized difference between CT-determined and known
iodine concentration for the three patient sizes. However, this
result is likely caused by higher measurement errors in small
and medium patient sizes for the 150Sn/100 kVp protocol.
Still, one should be careful when comparing the quantification
of iodine concentration between different patient sizes for both
scan techniques.
The present study has several limitations that need to be
recognized. The most important limitation is that measuring
iodine in several separate tubes in a thoracic phantom is dif-
ferent from measuring iodine concentrations in patients.
Movement of the heart, breathing motion and general move-
ment are not taken into account in this model, but are likely to
influence the iodine quantification in patients. These move-
ment problems could be especially problematic when low and
high energy data are not acquired at exactly the same time and
position, like in most DECT approaches. Water was used for
diluting iodine, which is different to clinical practice where
surrounding tissue such as calcium and proteinsmay influence
the iodine measurements. Furthermore, the ROIs were larger
(over 5.0 cm2), which will not always be applicable in clinical
practice. Smaller ROIs could increase the measurement error.
However, these results form a strong basis from which other
studies in iodine quantification using DECT can derive a se-
lection of protocols or kVp combinations. A second limitation
is that we limited the dual energy modes to third-generation
DSCT and first-generation DLCT, while there are other dual
energy methods on the market. The results presented in this
study could be different for other methods of iodine quantifi-
cation using different CT scanners. The third limitation is the
range in iodine concentration. The first patient study provid-
ing iodine quantification showed that the measured iodine
concentration ranges between 1 and 6 mg/ml. This is at the
lower end of the concentration range we used in this study.We
chose the current range of iodine concentrations to be able to
compare to the study by Koonce et al. [10].
Conclusion
Overall, both third-generation DSCT and first-generation
DLCT showed highly accurate quantification of increasing
iodine concentrations using DECT protocols. Best results
were found for DSCT using the 150Sn/70 or 150Sn/80 kVp

























































Fig. 5 Normalized difference
between the CT-measured and
known iodine concentration is
shown for the kVp combinations
available at DLCT by patient size.
A decrease in CT-determined io-
dine can be distinguished for all
kVp combinations, although the
trend was not significant
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DLCT. For both systems largest energy separation provided
the most accurate iodine quantification.
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